Table 1.
Paper | Type of Study and Level of Evidence | Compound/Extract | Sample | Posology/Treatment | Main Results |
---|---|---|---|---|---|
Nangia-Makker et al. [25] | Animal study (level 6) |
Ocimum gratissimum (holy basil) aqueous extract | MCF10ADCIS.com cells injected in female nude mice | 4 mg/mL lyophilized Ocimum gratissimum, hydrophobic or hydrophilic fractions | Slowed down MCF10ADCIS.com tumor growth and progression |
Taie et al. [26] | Animal study (level 6) |
Ocimum basilicum (sweet basil) leaves’ ethanolic extract |
Ehrlich ascites carcinoma cell line injected in female Swiss albino mice 22–25 g; 8–10 weeks old | Ethanolic extracts with 1250, 1500, 1750, or 2000 ppm, with oil extracted from them (0.04, 0.06, 0.08, and 0.10 mg) |
Ocimum ethanolic extract and oil with various concentrations changed the viability of Ehrlich ascites carcinoma cells in comparison with untreated cells |
Mahmoud [27] | Animal study (level 6) |
Ocimum basilicum (basil estragole chemotype) + fresh Tagetes minuta flowers (marigold) (100 g of each) were hydro-distilled | Ehrlich ascites carcinoma cell line (EACC) injected in 48 female Swiss albino mice weighting 20–25 g; 7–8 weeks old | Several volumes of marigold and basil essential oils to finalize with 25, 50, 75, 100, and 200 µg/mL concentrations | Essential oils significantly prevented tumor development (i.e., decreased total EACC number and increased the percentage of dead cells). The pre-initiation treatment was most effective compared to the initiation and post-initiation treatments, with marigold being more effective (i.e., higher percentage of dead cells) |